pharmaphorum1h
FDA clears Neurocrine drug for rare adrenal disorder
The FDA has approved Neurocrine Bioscience's Crenessity for classic congenital adrenal hyperplasia (CAH), the first drug for ...
Pharmabiz5h
US FDA approves Neurocrine Biosciences’ Crenessity to treat children and adults with classic congenital adrenal hyperplasia
US FDA approves Neurocrine Biosciences’ Crenessity to treat children and adults with classic congenital adrenal hyperplasia: San Diego Monday, December 16, 2024, 16:00 Hrs [IST] ...
US FDA approves Neurocrine Biosciences' genetic disorder drug
The U.S. Food and Drug Administration has approved Neurocrine Biosciences' drug to treat a type of genetic disorder, the ...
Neurocrine Wins FDA Approval For Genetic Disorder Drug
Neurocrine Biosciences won Food and Drug Administration approval late Friday for the first new treatment for an adrenal ...
Daily1d
FDA Approves Crinecerfont for classic Congenital Adrenal Hyperplasia
The US Food and Drug Administration has approved Crinecerfont for treatment of classic congenital adrenal hyperplasia, ...
Too Old to Operate11d
Psychosocial Factors and Rising Hospitalizations for AI and AC
The following is a summary of “Adrenal Crisis and Adrenal Insufficiency Admissions in Patients 30–59 Years: Contribution of ...
News Medical on MSN13d
Women with premature ovarian insufficiency face higher risk of autoimmune diseases
Research reveals a significant association between premature ovarian insufficiency and autoimmune diseases, highlighting ...
Neurocrine's CRENESSITY Gains FDA Approval For Treating Congenital Adrenal Hyperplasia
Neurocrine Biosciences, Inc. (NBIX) said that the U.S. Food and Drug Administration has approved CRENESSITY (crinecerfont) capsules ...